Cargando…
Exploration of time points and cut-off values for early tumour shrinkage to predict survival outcomes of patients with metastatic colorectal cancer treated with first-line chemotherapy using a biexponential model for change in tumour size
BACKGROUND: Several studies reported that early tumour shrinkage (ETS) was associated with overall survival in patients with metastatic colorectal cancer (mCRC) treated with first-line chemotherapy. However, appropriate time point and cut-off value for ETS remain unclear because these varied in prev...
Autores principales: | Sakamaki, Kentaro, Kito, Yosuke, Yamazaki, Kentaro, Izawa, Naoki, Tsuda, Takashi, Morita, Satoshi, Boku, Narikazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5687555/ https://www.ncbi.nlm.nih.gov/pubmed/29177097 http://dx.doi.org/10.1136/esmoopen-2017-000275 |
Ejemplares similares
-
Differentiating tumour progression from pseudoprogression in glioblastoma patients: a monoexponential, biexponential, and stretched-exponential model-based DWI study
por: Liao, Dan, et al.
Publicado: (2023) -
Impact of panel design and cut-off on tumour mutational burden assessment in metastatic solid tumour samples
por: Mankor, Joanne M., et al.
Publicado: (2020) -
How to define a cut-off value of tumour markers in haemodialysis patients?
por: Mercadal, Lucile, et al.
Publicado: (2009) -
Diminished liver microperfusion in Fontan patients: A biexponential DWI study
por: Dijkstra, Hildebrand, et al.
Publicado: (2017) -
Clinical impact of primary tumour location, early tumour shrinkage, and depth of response in the treatment of metastatic colorectal cancer with first-line chemotherapy plus cetuximab or bevacizumab
por: Sagawa, Tamotsu, et al.
Publicado: (2020)